Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody) at the 2022 American Society of Hematology Annual Meeting ...Middle East

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic,...

Hence then, the article about innovent presents phase 1b clinical data of ibi188 anti cd47 monoclonal antibody at the 2022 american society of hematology annual meeting was published today ( Sunday 11/12/2022 - 03:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody) at the 2022 American Society of Hematology Annual Meeting )

Also on site :

• Firefighters fight police in France (VIDEOS)
• The NFL Names Its First-Ever 'Chief Kindness Officer' Ahead of Super Bowl LX
• 1990 Tearjerker Voted ‘Best Country Song’ of All Time